Kitazato (TSE:368A) Debt-to-Equity: 0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:368A Kitazato Corp TSE:368A
20 GF Score
Price 円1,462.00
! 1 Warning Sign
View Full Analysis

What is Kitazato Debt-to-Equity?

Kitazato TSE:368A -0.48% 20 Debt-to-Equity is 0.00 as of Jun. 2026. GuruFocus rates TSE:368A with a GF Score™ of 20/100. The stock has 1 warning sign investors should review. Among 698 Medical Devices & Instruments companies, Kitazato ranks worse than 143266.33% on this metric.

Kitazato's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was 円0 Mil. Kitazato's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was 円48 Mil. Kitazato's Total Stockholders Equity for the quarter that ended in Jun. 2026 was 円19,871 Mil. Kitazato's debt to equity for the quarter that ended in Jun. 2026 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Kitazato's Debt-to-Equity or its related term are showing as below:

TSE:368A's Debt-to-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.24
* Ranked among companies with meaningful Debt-to-Equity only.

Kitazato  (TSE:368A) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Kitazato Debt-to-Equity Related Terms

Kitazato Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Kitazato's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kitazato Debt-to-Equity Chart

Kitazato Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Debt-to-Equity
0.01 0.01 0.01 0.01

Kitazato Quarterly Data
Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-Equity Get a 7-Day Free Trial 0.01 0.00 0.00 0.01 0.00

TSE:368A vs ISRG, BDX, RMD: Debt-to-Equity Comparison

For the Medical Instruments & Supplies subindustry, Kitazato's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kitazato Debt-to-Equity vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kitazato's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Kitazato's Debt-to-Equity falls into.


TSE:368A
20GF Score
Kitazato Corp TSE:368A
Debt-to-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kitazato Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Kitazato's Debt to Equity Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(41 + 61) / 20504
=0.00

Kitazato's Debt to Equity Ratio for the quarter that ended in Jun. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 48) / 19871
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of 0.00 mean?
Kitazato (TSE:368A) has a Debt-to-Equity of 0.00 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Kitazato and its competitors. According to the industry distribution chart, Kitazato ranks #999999 out of 698 companies in the Medical Devices & Instruments industry.
Is Kitazato's Debt-to-Equity too high?
Kitazato's current Debt-to-Equity is 0.00. Based on the distribution chart, Kitazato ranks #999999 out of 698 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Kitazato has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Kitazato's Debt-to-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Kitazato ranks #999999 out of 698 companies for Debt-to-Equity. This places Kitazato in the lower half of its industry. The industry median Debt-to-Equity is 0.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.24, based on 698 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Kitazato and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kitazato's current Debt-to-Equity is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kitazato stock overvalued right now?
Kitazato (TSE:368A) has a current Debt-to-Equity of 0.00. The current Debt-to-Equity is 0.00. Kitazato's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Kitazato (TSE:368A), the current Debt-to-Equity is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kitazato Business Description

Address 100-10 Yanagishima, Fuji-shi, Shizuoka, JPN, 416-0932
Kitazato Corp is engaged in manufacture and sale of medical devices and related products for fertility treatment. Its products include Needles, Catheters and Cannulas, Vitrification Media and Equipments, Sperm Processing Medium/Tools, IVF Medium, etc.
20GF Score

Get the complete analysis for TSE:368A

Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,462.00
Price